Physician

Christopher L Willingham, M.D.

According to 2025 Medicare claims, Christopher Willingham, M.D. (NPI: 1225096183) practices ophthalmology in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is SOUTHERN VITREORETINAL ASSOCIATES, PL (NPI: 1871665448; TIN: 208515285) and primary practice location at 32405-4902.

Willingham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 759 traditional Medicare patients, billed 35,157 HCPCS/CPT codes, and received $1,942,172 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 649 prescription claims across 185 beneficiaries totaling $36,303 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 24 records totaling $525. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $33,929 to $36,303. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,006	11,580	$2,302,947
2016	968	11,884	$2,448,832
2017	926	11,184	$2,336,526
2018	876	10,473	$2,187,305
2019	764	9,812	$1,987,443
2020	725	9,962	$1,988,994
2021	785	10,820	$2,227,363
2022	765	13,000	$2,101,367
2023	758	22,385	$1,924,097
2024	759	35,157	$1,942,172

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	127	642	$33,929
2016	133	1,210	$66,429
2017	140	1,787	$90,528
2018	122	909	$49,868
2019	117	431	$22,978
2020	120	504	$27,218
2021	111	500	$28,726
2022	141	529	$28,600
2023	157	573	$36,823
2024	185	649	$36,303

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	131	144	$100
67028	Injection of drug into eye	277	1,620	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	370	488	$65
92134	Imaging of retina	574	1,748	$30
92250	Photography of the retina	104	160	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	133	7,346	$8,401
Combigan	Brimonidine Tartrate/Timolol	19	770	$6,172
Ketorolac Tromethamine	Ketorolac Tromethamine	32	801	$912
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	43	3,075	$736
Atropine Sulfate	Atropine Sulfate	21	852	$617

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$525	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$280,063	US Retina LLC

Explore More Providers

FAQ

What Medicare data is available for Christopher L. Willingham, M.D.?

Tedicare shows public-source Medicare data for Christopher L. Willingham, M.D. (NPI 1225096183), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher L. Willingham, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher L. Willingham, M.D.?

Christopher L. Willingham, M.D. is linked to SOUTHERN VITREORETINAL ASSOCIATES, PL (billing NPI 1871665448) in the available physician profile data.

Does Christopher L. Willingham, M.D. have Open Payments data?

Christopher L. Willingham, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.